The significance of galectin-3 as a new basal cell marker in prostate cancer (original) (raw)
Involvement of decreased Galectin-3 expression in the pathogenesis and progression of prostate cancer
Arnulf Stenzl
The Prostate, 2008
View PDFchevron_right
Differential expression of galectins in normal, benign and malignant prostate epithelial cells: silencing of galectin-3 expression in prostate cancer by its promoter …
HAFIZ KHALIL AHMED
Biochemical and biophysical research …, 2007
View PDFchevron_right
Regulation of Prostate Cancer Progression by Galectin-3
Pratima Nangia-Makker
The American Journal of Pathology, 2009
View PDFchevron_right
Differential expression of galectins in normal, benign and malignant prostate epithelial cells: Silencing of galectin-3 expression in prostate cancer by its promoter methylation
Hafiz Ahmed
Biochemical and Biophysical Research Communications, 2007
View PDFchevron_right
Supplementary Tables 1-2 from A Unique Galectin Signature in Human Prostate Cancer Progression Suggests Galectin-1 as a Key Target for Treatment of Advanced Disease
Elba Vazquez
View PDFchevron_right
A Unique Galectin Signature in Human Prostate Cancer Progression Suggests Galectin-1 as a Key Target for Treatment of Advanced Disease
Elba Vazquez
2013
View PDFchevron_right
Galectin-3 in Prostate Cancer Stem-Like Cells Is Immunosuppressive and Drives Early Metastasis
Antonella Monno
Frontiers in Immunology, 2020
View PDFchevron_right
Targeting Galectin-1 impairs castration-resistant prostate cancer progression and invasion
Hsing-jien Kung
Clinical cancer research : an official journal of the American Association for Cancer Research, 2018
View PDFchevron_right
Positive associations between galectin-3 and PSA levels in prostate cancer patients: a prospective clinical study-I
Daryn Smith
Oncotarget, 2015
View PDFchevron_right
Galectins as New Prognostic Markers and Potential Therapeutic Targets for Advanced Prostate Cancers
Diego Laderach
Prostate Cancer, 2013
View PDFchevron_right
Stable and high expression of Galectin-8 tightly controls metastatic progression of prostate cancer
Anne Chauchereau
Oncotarget, 2017
View PDFchevron_right
Molecular characterization of prostate carcinoma tumor antigen-1, PCTA-1, a human Galectin-8 related gene
Rahul Gopalkrishnan
Oncogene, 2000
View PDFchevron_right
Immunochemiluminescent detection of galectin-3 in tumoral tissue from prostate
Luiz Carvalho
International journal of clinical and experimental pathology, 2013
View PDFchevron_right
Decreased expression of galectin-3 predicts tumour recurrence in pTa bladder cancer
David Schilling
Oncology Reports, 1994
View PDFchevron_right
Diagnostic and Prognostic Significance of Serum and Tissue Galectin 3 Expression in Patients with Carcinoma of the Bladder
Hani Nour
Current Urology, 2013
View PDFchevron_right
Evidence of heavy methylation in the galectin 3 promoter in early stages of prostate adenocarcinoma: Development and validation of a methylated marker for early diagnosis of prostate cancer
Vito Rodolico
2009
View PDFchevron_right
Galectins and urological cancer
Yukinori Takenaka
Journal of Cellular Biochemistry, 2004
View PDFchevron_right
Gene expression relationship between prostate cancer cells of Gleason 3, 4 and normal epithelial cells as revealed by cell type-specific transcriptomes
P. Troisch, Laura Pascal, Alvin Liu
BMC Cancer, 2009
View PDFchevron_right
Alterations in Galectin-3 Expression and Distribution Correlate with Breast Cancer Progression
Pratima Nangia-Makker
The American Journal of Pathology, 2004
View PDFchevron_right
Tyrosine-phosphorylated Galectin-3 Protein Is Resistant to Prostate-specific Antigen (PSA) Cleavage
Pratima Nangia-Makker
Journal of Biological Chemistry, 2012
View PDFchevron_right
Galectin-3 expression is associated with bladder cancer progression and clinical outcome
Manuel Urrutia
Tumor Biology, 2010
View PDFchevron_right